The formation and function of the Mesothelioma Panel of the
Commission of the European Communities. Industrial health and safety. EUR 14522 EN by Jones, J.S.P.
COMMISSION 
OF THE EUROPEAN COMMUNITIES 
Report 
EUR 14522 EN 
ISSN 1  018-5593 
The formation and 
function of the 
Mesothelioma Panel 
of the 
Commission of the 
European Communities 
Health and safety The formation and function of the 
Mesothelioma Panel of the 
Commission of the European Communities Health and safety series 
Contract No 91 E2-001-S tf'-1~7  33!r?2Z  ~.2F,S3 
(.STc:176.~ 
Commission of the European Communities 
The formation and function 
of the l\1iesothelioma Panel of the 
Commission of the European Communities 
1993 
J.S.P. Jones 
It 
Department of Pathology 
City Hospital 
Hucknall Road 
Nottingham NG5 1  PB 
United Kingdom 
On behalf of the 
Commission of the European Communities 
L-2920 Luxembourg 
Directorate-General 
Employment, Industrial Relations and Social Affairs 
EUR 14522 EN 
c  C:  t.:  •  v j c.,  1
/ Published by the 
COMMISSION OF THE EUROPEAN COMMUNITIES 
Directorate-General 
Information Technologies and Industries, and Telecommunications 
L-2920 Luxembourg 
LEGAL NOTICE 
Neither the Commission of the European Communities nor any person acting 
on behalf of the Commission is responsible for the use which might be made of 
the following information 
Cataloguing data can be found at the end of this publication 
Luxembourg: Office for Official Publications of the European Communities, 1993 
ISBN 92-826-4821-4 
© ECSC-EEC-EAEC, Brussels • Luxembourg, 1993 
Printed in France THE  FORMATION  AND  FUNCTION 
of  the 
MESOTHELIOMA  PANEL 
of  the 
COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
INTRODUCTION 
TERMS  OF  REFERENCE 
VOTING  PROCEDURE  FOR  THE  DEGREE  OF  CONFIDENCE  IN  DIAGNOSING  DIFFUSE 
MALIGANT  MESOTHELIOMA 
PROGRESS  OF  THE  CEC  MESOTHELIOMA  PANEL 
ESTABLISHMENT  OF  A FORMAL  POSTAL  CIRCULATION  SYSTEM 
DIRECTIVE  ON  ASBESTOS  WITHIN  THE  EEC 
CRITERIA  FOR  THE  DIAGNOSIS  OF  MESOTHELIOMA 
OBSERVER  VARIATIONS 
CAUSAL  RELATIONSHIPS 
EDUCATIONAL  ROLE  OF  THE  PANEL 
ACHIEVEMENTS  AND  THE  FUTURE 
APPENDIX  I  Members  of  the  Panel 
II  Form  for  submission  of a case 
III  Form  for  voting  on  a case 
IV  Example. of opinions  on  a case 
V  Summary  of_Results  of  the first 200  cases  submitted 
to the  CEC  Mesothelioma  Panel 
VI  References 
v INTRODUCTION 
A  period  of  gradual  evolution  preceded  the  actual  formation  of  the 
Mesothelioma  Panel  of  the  Commission  of  the  European  Communities 
(hereafter  referred  to  as  the  CEC  Mesothelioma  Panel).  After  the 
publication  in  1960  of  the  paper  by  Wagner,  Sleggs  and  Marchand  on  the 
connection between asbestos  exposure  and mesothelioma  formation,  it became 
apparent  over  the  succeeding  decade  that  a  potentially  serious  health 
problem  existed. In  1974,  at  a  meeting  of  the  International  Academy  for 
Environmental  Protection held  in Vienna,  Professor J.  Clemessen  (Denmark) 
proposed a  scheme  for  the  "Monitoring of Environmental  Carcinogens  through 
Employers'  Records".  Shortly before this,  a  similar proposal had been made 
to the International Labour Organisation  (ILO)  by Dr  Robert Murray  (United 
Kingdom).  Professor  Clemessen's  recommendations  were  then  made  to  a 
working  group  of  the  Committee  on  Medical  Research  and  Public  Health  of 
the  Commission of the  European Communities. 
In  the  period  1975-1976  the  Health  and  Safety  Directorate  of  the 
Commission  of  the  European  Communi ties  organized  meetings  of  a  Working 
Group  of  experts,  in  order  to  agree  for  publication  a  report  entitled 
"Public  Health  Risks  of  Exposure  to  Asbestos"  (EUR  5653e).  This  report 
contained  several  conclusions  and  recommendations;  one  of  the  latter 
steted that  "a  mesothelioma  register  should  be  set  up  in  those  countries 
of  the  EEC  where  non  exist,  in  accordance  with  criteria  and  procedures 
agreed upon by  a  panel of pathologists". 
In  this  context,  a  meeting  was  convened  in  Luxembourg  in  1976  under  the 
Chairmanship of Dr  W.J.  Hunter of the Health  and Safety Directorate of the 
Commission of the  European  Communities.  The  participants were  pathologists 
and epidemiologists  from  a  number  of the Member  Countries of the  Community 
who  had  a  special  interest  in  asbestos-associated  diseases.  Asbestos  was 
considered  to  be  a  first  category  pollutant  requiring  priority 
investigation within  the  Action  Programme  of  the  European  Communities  on 
the  Environment. 
The  meeting  was  originally  convened  to  discuss  the  feasibility of  an  EEC 
Cancer  Register.  In  particular,  consideration  was  to  be  given  to  two 
specific points: 
1 - the  role,  if any,  of  a Mesothelioma  Register  within  the  broader  context 
of a  Cancer  Register 
- the  basic  information  requirements  for  a workable  Mesothelioma  Register. 
During  the  discussions  that followed  it was  felt that the  creation of a 
European  Cancer  Register  would  be  impractical.  The  methods  for 
verification of diagnosis  and  certification of death  varied  so  much  in 
different countries  that the  accuracy  of  such  a  generalised  register would 
be  open  to  doubt.  In  particular the  different attitudes  to  post  mortem 
examinations  amongst  the  Member  Countries  could  produce  biased  results. 
The  concept  of a  general  Cancer  Register  was  therefore  thought  to  be  too 
cumbersome  to  contemplate.  However  Dr  J  C Wagner  (United  Kingdom) 
suggested  that a Mesothelioma  Register  was  a  far more  feasible  target to 
aim  for,  and  this  proposal  was  accepted. 
Professor J  Bignon  (France)  considered  that the  only  way  to  obtain accurate 
information  for  inclusion  in  the  Mesothelioma  Register  was  through 
pathologists.  Dr  Frentzel  (W.Germany)  suggested  that a  panel  of 
pathologists  be  created to study  the  comparability of diagnosis,  similar 
to  that created  in  Germany  to  study  primary  bone  tumours.  Dr  M  Greenberg 
(United  Kingdom),  in  supporting  the  proposal,  suggested  that the  concept 
of  the  Mesothelioma  Register should  be  limited to  studies which  could  be 
performed  in  depth  on  a  selective basis. 
Dr  H Planteydt  (Netherlands)  and  Dr  S Jones  (United  Kingdom)  presented 
papers  which  illustrated the  ways  in  which  mesothelioma  surveys  had  been 
carried out  in  their respective  countries.  They  drew  attention to -the 
practical  difficulties of obtaining  accurate  information.  It was  clearly 
essential  that epidemiologists  and  statisticians would  need  to  have  the 
best diagnostic  information  available  in  order  to  study  occupational 
2 causation  of disease  and  disease  trends.  This  could  only  be  provided  by 
pathologically confirmed  cases  of  mesothelioma. 
It was  agreed  that from  a  practical  point  of  view  it would  not  be  possible 
to  create an  EEC  Mesothelioma  Register  that could  from  the  beginning  meet 
all  the  requirements.  It was  therefore  suggested  that a  phased  programme 
be  instituted,  as  follows:-
1.  A Mesothelioma  Register  be  instituted in  each  individual  Member  Country 
based  on  general  mortality statistics. 
2.  Pathologists  in  each  Member  Country  be  asked  to.  report all  cases  of 
mesothelioma  diagnosed  by  them  to their own  national  Mesothelioma  Registers. 
3.  Encouragement  should  be  given  to  the  creation of Mesothelioma  Panels  in 
each  Member  Country  in  order  to  standardize  the  histopathological  diagnosis. 
4.  A Mesotheljoma  Panel  of  the  Commission  of  the  European  Communities 
be  established to develop  standardized  histopathological  criteria for 
diagnosis. 
5.  Eventual  integration of data  from  each  Member  Country  be  carried out. 
As  a  general  guidance,  the  type  of  information  that should  be  sought  in 
each  individual  case  should  be  as  follows:-
a)  The  type  of  primary  serosal  tumour  (pleura,  peritoneum,  pericardium, 
tunica  vaginalis) 
b)  Date  of  birth 
c)  Date  of death 
d)  Sex 
e)  Name 
f)  Occupations  throughout  life of  individual  and  of  spouse 
g)  Places  of residence 
h)  Identity numbers  (eg  social  security,  health  service or  pathology 
specimen  numbers). 
3 TERMS  OF  REFERENCE  OF  THE  CEC  MESOTHEliOMA  PANEl 
These  were  formulated  ~~  ~  meeting  held  in  Middelburg  (Netherlands)  ~, 
~ay 1977.  They  were  as  follows:-
1.  The  Panel  has  as  one  of  its basic  objectives  the  standardization of 
the  pathological  diagnosis  of mesothelioma  by  exchange  of  information 
between  Members  of  National  Panels. 
2.  The  Panel  should  provide  data  which,  when  combined  with  information 
from  clinical  and  epidemiological  sources,  can  be  used  for  the 
compiling of  the  EEC  Mesothelioma  Register. 
3.  The  Panel  should  consist of  one  pathologist from  each  Member  State, 
who  has  experience  of primary  tumours  of  the  serosal  cavities and  of 
asbestosis. 
4.  The  Panel  should  be  able  to  co-opt  pathologists with  spe~ialized 
knowledge,  eg  of  gastro-intestinal  tumours,  or  tumours  of  the  female 
genital  tract. 
5.  The  Panel  should  have  statistical  advice  for  the  planning  of  its 
function. 
6.  The  Panel  should  consider  the  amount  of  biopsy  material  required  to 
make  a definitive diagnosis,  especially in  relation to  needle  biopsies. 
7.  The  Panel  should  determine  whether  or  ~ot deleterious effects follow 
the  practice of  taking  biopsies  by  open  thoracotomy. 
4 8.  The  Panel  should  attempt  to  establish· the  dose/response 
relationship between  asbestos  expo3ure  and  mesothelioma  formation. 
This  should  be  considered  in  cases  subjected  to  post  mortem  examination 
when  tumour  tissue can  be  examined  histologically and  when  mineral 
analysis  (concentrations  of  fibres  and  typing  of  fibres)  can  be  performed 
on  samples  taken  from  a  saggital  section of  lung  tissue. 
9.  The  Panel  should  agree  on  a classification scheme  for mesotheliomas 
and  a  voting  system  concerning  the  confidence  of diagnosis. 
10.  The  Panel  should  agree  on  a classification scheme  for assessing  the 
degree  of  severity of asbestosis  in  the  lung  tissue of  patients  in 
whom  mesothelioma  has  been  diagnosed. 
5 VOTING  PROCEDURE  FOR  THE  DEGREE  OF  CONFIDENCE  IN  DIAGNOSING  DIFFUSE 
MALIGNANT·  MESOTHELIOMA 
It was  accepted  that in  some  cases  it was  possible  for a  pathologist to 
come  to a  positive conclusion  on  both  macroscopic  and  microscopic  grounds 
that a  given  tumour  definitely was  a mesothelioma,  or  that another 
tumour  definitely was  not a mesothelioma.  It was  also accepted  that there 
remained  areas  of  uncertainty  in  many  cases  as  to  a  definite diagnosis. 
It was  regarded  as  being  essential  that the  system  to  be  used  for 
recording  the  diagnoses  of the  various  members  of  the  Mesothelioma  Panel 
should  be  as  simple  as  possible. 
It was  therefore decided  to  adopt  the  scheme  used  by  McCaughey  and  Oldham 
(1973),  by  the  Netherlands  Mesothelioma  Panel  (Planteydt,  1980)  and  by  the 
IARC  Mesothelioma  Panel  of  the  United  Kingdom  (Jones  et al, 1980).  This 
scheme  determined  the  degree  of certainty of diagnosis,  and  it was  agreed 
that it should  be  carried out  on  a trial  basis  to  test its effectiveness. 
Five  categories  of opinion  were  defined,  as  follows:-
OPINION 
A.  Definite mesothelioma  - No  doubt  about  tne diagnosis,  ie both  macroscopic 
and  microscopic  criteria were  fulfilled. 
B.  Probable .esothelioma - Some  reservations  about  the diagnosis,  ie not 
all  the diagnostic criteria were  fulfilled,  possibly due  to sampling 
limitations,  but  there was  reasonable  evidence  present  to  support  the 
diagnosis. 
C.  Possible mesothelioma  - The  diagnosis  can  neither be  fully supported 
nor  excluded. 
D.  Probably  not a mesothelioma  - The  diagnosis  could  not  entirely be 
excluded. 
6 E.  Definitely not  a mesothelioma  - Some  tumours  could  mimic  a mesothelioma 
macroscopically,  but  histologically the  diagnosis  could  be  positively 
rejected.  The  lesions could  be  reactive,  or  be  neoplasms  which  were 
not  of mesothelial  origin. 
7 PROGRESS  OF  THE  CEC  MESOTHEliOMA  PANEl 
At  a meeting  in  Alessandria  and  Turin,  Italy,  in  September  1978, 
Dr  W  Hunter  explained  the  action  programme  that  had  been  devised  by  the 
Health  and  Safety  Directorate  of  the  European  Commissioners  relating  to 
asbestos.  It was  intended  that there  should  be  a continuing  existence 
of  the  CEC  Mesothelioma  Panel  and  plans  were  proposed  for it to meet  on 
a more  regular  and  formal  basis. 
Since  the  meeting  in  Middelburg,  a  number  of  tumour  sections  had  been 
circulated to  Members  on  an  informal  basis.  Members  also  presented 
further diagnostic  problems  which  were  discussed  in  a  round  table 
microscopic  session.  Attempts  were  made  to  classify these  under  a coding 
system  prepared  by  Professor J  Clemmeson.  Consideration  was  given  to  the 
use  of the  term 
11mesodermoma
11  rather than  mesothelioma,  as  proposed  by 
Professor A Donna  (Italy).  This  related to  mesothelial  neoplastic 
lesions  based  on  their embryonic  origin.  The  name 
11mesodermoma
11  was 
intended  to embrace  all primary  tumours  arising  in  the  pleura,  not  only 
mesotheliomas.  While  the  embryological  concept  could  undoubtedly  explain 
some  of  the  variants  of  the  primary  serosal  tumours,  from  a  practical 
point of  view  it was  thought  that most  pathologists  were  developing  a clear 
idea  of  the  diagnostic criteria for mesotheliomas,  and  that this  term 
should  be  adhered  to. 
It was  noted  that in  many  countries  the  number  of autopsies  that were 
carried out were  very  few  and  this  factor alone  would  limit the  diagnostic 
opportunities  and  distort the  statistics.  Every  encouragement  should  be 
given  to  increase  the  number  of autopsies,  particularly in  those  cases 
where  an  occupationally-related disease  might  be  a contributory factor 
to  death. 
8 DIRECTIVE  ON  ASBESTOS  WITHIN  THE  EEC 
At  the  Dortmund  meeting  in  1979  Dr  Hunter  informed  the  Panel  members  that the 
European  Commission  had  issued  a 
11Proposal  for  a Council  Directive  on  the 
protection  of  workers  from  harmful  exposure  to  chemical,  physical  and 
biological  agents  at work
11
•  This  envisaged  an  individual  Directive  on 
asbestos. 
Dr  Wagner  presented  a  report  prepared  by  himself  and  Dr  P C Elmes  (United 
Kingdom)  on 
11The  Establishment  of a Mesothelioma  Register  in  the  E.E.C.
11 
If it could  be  implemented  it would  help  health  authorities  in  the  Member 
Countries  to  determine:-
a)  the  extent of  the  problem 
b)  the  association with  asbestos  exposure,  or other  pollutants 
c)  future  trends 
The  report detailed  the  different ways  in  which  the  Member  Countries 
could  collect information,  and  it emphasised  that some  uniform  method 
would  be  advantageous.  The  following  suggestions  were  discussed:-
1.  That  a Mesothelioma  Register  be  set up  in  the  EEC. 
2.  That  information  for  this  Register would  depend  on  efficient Registers 
being  established  in  Member  Countries. 
3.  That  the  Registers  in  these  Countries  should  be  under  the  control  of 
the  Government  departments  which  were  responsible  for  Health  and  Safety. 
4.  That  those  running  the  Register  should  be  advised  by  a  panel  of 
epidemiologists  supported  by  a  panel  of clinicians/radiologists,  and  the 
panel  of pathologists. 
5.  That  it was  essential  that detailed  information  should  be  recorded 
on  the  Death  Certificates as  issued  now  in  all  Member  Countries.  This 
9 information  should  be  made  available  to.responsible  people  engaged  in 
epidemiological  studies. 
6.  That  the  information  on  individuals  be  kept  confidential. 
7.  That  autopsies  should  be  undertaken  on  all  those  who  have  died  from, 
or were  suspected  of  having  died  from  diffuse malignant  mesothelioma  of 
the  pleura  and/or  peritoneum,  whether  there  has  been  a  history of 
occupational  exposure  to  fibrous  minerals,  or not. 
8.  That  initially it may  be  advisable  to  undertake  pilot studies  in  an 
industrial  and  a  rural  area  in  all  countries  which  are  Members  of  the 
European  Community.  Later,  the  scheme  may  be  enlarged  to  cover  the  whole 
of each  Country. 
9.  That  wherever  possible,  the  dust  content of the  lungs  removed  at 
autopsy  should  be  analysed,  both  to  confirm  histories of  exposure  and  to 
see  if fibrous  dusts  other than  asbestos  are  present. 
10.  That  it would  be  of great  importance  that the  Register  was  to  be 
set up  by  a competent  epidemiologist  who  has  experience  in  this type  of 
organisation. 
The  work  of  the  CEC  Mesothelioma  Panel  was  underlined  by  the touncil  of 
Ministers  in  a  Directive  in  1983  on  the  protection of workers  from  the 
risks  related to  asbestos  at work.  This  required  Member  Countries  to 
keep  a  Register of  recognized  cases  of mesothelioma.  The  accuracy  of 
the  Registers  would  naturally  be  dependent  on  reliable diagnostic 
information.  It was  therefore essential  that pathologists  supply 
reliable data.  The  CEC  Mesothelioma  Panel  therefore embarked  on  two 
major  projects:-
1.  To  write  a  book,  primarily  intended  for  pathologists,  which 
illustrated the  macroscopic  and  microscopic  criteria for  the  diagnosis 
of mesotheliomas.  This  was  prepared  by  Drs  Lund,  Jones  and  Planteydt. 
10 It was  entitled 
11A Colour  Atlas  of Mesothelioma ..  and  it was  published  in 
1985  by  MTP  Press  Ltd  under  the  sponsorship  of  The  Commission  of  the 
European  Communities. 
2.  To  devise  a  programme  to  explore  new  diagnostic methods,  particularly 
of  histochemical  and  immunohistochemical  techniques  which  might  assist 
pathologists  in  coming  to  concise  conclusions,  particularly with  respect 
to  small  biopsy  samples  taken  during  life. 
11 ESTABLISHMENT  OF  A FORMAL  POSTAL  CIRCULATION  SYSTEM 
At  the  meeting  of  the  CEC  Mesothelioma  Panel  in  Dortmund,  Germany  in 
May  1979  it was  agreed  that members  should  submit  cases  of  interest, 
or of  particular diagnostic  difficulty,  for  postal  circulation around 
the  Panel.  A system  was  to  be  devised  for  correlating the  various 
opinions,  and  for  the  maintenance  of  a  tumour  registry.  The  Department 
of  Histopathology  at the  City  Hospital,  Nottingham  was  contracted  to 
provide  the  technical  and  secretarial  support  for  the  scheme  which  would 
be  co-ordinated  by  Dr  Jones. 
Members  were  asked  to  submit  paraffin-embedded  blocks  of  formalin-fixed 
tissues,  together with  occupational,  clinical  and  pathological  details 
for each  case.  Sections  would  be  cut  (  1 haematoxylin  and  eosin-stained, 
and  three  unstained  spares  ) at the  co-ordinating centre,  and  the  sets 
would  be  sent to  each  member  of  the  CEC  Mesothelioma  Panel.  Members  would 
carry out  additional  stains of their own  choice  in  their own  laboratories. 
A summary  of the  clinical  and  occupational  details would  also  be  sent to 
each  member  in  a  sealed envelope.  The  member  would  examine  the  sections 
microscopically  and  form  a  preliminary  opinion  before  opening  the 
envelope.  A further,  and  possibly a modified  opinion  would  be  given,  after 
consideration of all  the  factors. 
Each  member•s  opinion  was  to  be  recorded  on  a  standard  form  {Appendix  III) 
which  would  be  sent to  the  Nottingham  Centre.  When  all  the  opinions 
on  a  particular case  had  been  received,  a composite  report - giving  the 
results of each  member  - would  be  sent  to  all  members  of  the  Panel. 
Cases  of  particular interest or diagnostic  difficulty would  be  earmarked 
for  discussion  at the  next  meeting  of  the  Panel. 
12 CRITERIA  FOR  THE  DIAGNOSIS  OF  DIFFUSE  MALIGNANT  MESOTHELIOMA 
As  a  result of  the  study  of  many  cases  by  the  CEC  Mesothelioma  Panel 
the  following  criteria have  been  established:-
Macroscopic  The  neoplasm  should  have  the  appearance  of a  primary  tumour 
involving  either the  pleura  (figure  1),  peritoneum  (figure  2),  pericardium  or 
tunica vaginalis.  There  should  be  no  obvious  primary  site in  any  other organ 
which  might  suggest  that the  tu~our of  the  serosal  membrane  was  metastatic. 
Microscopic  The  classical  diagnostic  features  require  the  tumour  to 
have  a dimorphic  structure, with  both  "epithelial" and  "connective" 
tissue neoplastic  elements  present  (figures  3 &  4).  The  tumour  essentially has 
a marked  variability in  different  parts of  the  neoplasm.  In  some  areas  the 
"epithelial" element  my  predominate;  in  others,  the  "connective'tissue" 
element  may  predominate;  while  in  other zones  there  is a mixture  of 
11epithelial"  and  'iconnective  tissue'!  components.  The  wide  spectrum  of 
appearances  is depicted  in Figure  5,  which  shows  how  some  mesotheliomas 
can  mimic  carcinomas  at the  .. epithelial" end,  while  others  can  mimic 
sarcomas  at the  .. connective-tissue"  end. 
The  histopathologist should  not  be  surprised  to  find  differentiation 
of elements  in  the  connective  tissue type  of mesothelioma,  such  as 
cartilage,  bone,  muscle  and  even  occasionally fat.  Very  rarely,  areas 
of  squamous  metaplastic  change  are  seen  in  the  epithelial  type  of 
mesothelioma. 
While  most  diagnostic  information  can  be  gained  by  the  microscopic  study 
of  haematoxylin  and  eosin-stained  sections,  it may  be  necessary  to  use 
additional  staining  techniques  to  confirm  the  nature  of  the  tumour. 
13 The  most  useful  additional  stain is  the  diastase-PAS  stain which 
usually  is able  to  distinguish 
11epithelial
11  types  of mesotheliomas  from 
secondary  adenocarcinomas.  This  stain is negative  for mesotheliomas,  but 
is  usually  positive  in  mucin-secreting  adenocarcinomas.  If epithelial  mucin 
is seen,  the  diagnosis  of mesothelioma  must  be  rejected  in  favour  of 
adenocarcinoma. 
New  Diagnostic Methods 
The  diagnostic  value  of  immunohistochemical  stains  has  been  evaluated 
by  the  CEC  Mesothelioma  Panel  over  the  years. 
Carcino-Embryonic  Antigen  (CEA)  stain  This  reaction  may  vary  with  the 
used  antibody.  However  most  of  the  antibodies  give  negative  results 
for mesotheliomas  and  positive results  for  adenocarcinomas. 
Cytokeratin stain  This  is  usually  strongly  positive  in  mesotheliomas, 
but  may  be  weakly  positive  in  adenocarcinomas.  Certainly a  negative 
cytokeratin stain would  make  the  diagnosis  of mesothelioma  extremely 
dubious.  Cytokeratin  is also  useful  in  distinguishing a connective 
tissue type  of mesothelioma  (positive)  from  a  secondary  sarcoma  (usually 
negative). 
Vimentin  This  is  usually strongly positive  in  the  connective  tissue type 
of mesothelioma.  It may  also  be  positive  in  the  epithelial  element  of 
mesotheliomas.  However  some  pulmonary  adenocarcinomas  and  pleural 
metastases  from  other  primary  sources  may  also  react with  vimentin  antibodies. 
Two  techniques  have  been  introduced  at various  meetings  of  the  CEC 
Mesothelioma  Panel  by  Professor  Donna. 
1.  He  has  developed  an  immunohistochemical  stain which  is designed  to 
identify positively cells of mesothelial  origin, whether  they  are of 
benign  or malignant  type.  In  testing out  the  antibody  in  his  laboratory 
14 Professor  Donna  has  achieved  a  high  level  of correlation with  the 
histological  diagnosis  of  many  tumours  submitted  to  the  CEC  Panel. 
However  it has  not  been  possible  so  far to  achieve  such  a correlation when 
the  stain was  used  by  Panel  members  in  their own  laboratories. 
Professor  Donna  has  carried out  further  research  on  his  stain and  has  found 
that the  freshness  of  the  tissue and  the  mode  of  fixation  is critical  in 
order  to  obtain  consistent results.  Because  of  the  importance  of  trying 
to  establish a  stain which  would  positively and  selectively identify 
mesothelial  cells,  further work  will  be  carried out  in  an  endeavour  to 
improve  the  reproducibility of  the  technique. 
2.  Morphometric  (planimetry)  techniques  (an  assessment  of geometrical 
features  of structures  in  a  two-dimensional  plane)  have  been  shown  to 
differentiate between  benign  and  malignant  cells.  In  contrast to  this, 
ploidy  studies  which  have  been  carried out  using  either flow  cytometry 
(Burmer  et al,  1984)  or  static cytometry  (Tierney  et al,  1990)  were  unable 
to  produce  such  an  effective distinction.  Clearly,  this  is another  area 
where  further work  needs  to  be  carried out. 
15 OBSERVER  VARIATION 
At  the  meeting  of the  CEC  Mesothelioma  Panel  in  Athens  in  December, 
1988,  Professor  G Delides  (Greece)  presented  an  analysis  of the 
performance  of  the  Panel  members  in  relation  to  the  opinions  expressed  in 
the 
11A
11  to 
11E
11  postal  voting  system.  He  reported  that there  was  greater 
agreement  among  the  Panel  members  when  considering  the  earlier cases, 
rather than  the  more  recent ones.  While  it might  be  expected  that the 
increased  experience  gained  by  members  would  lead  to  a  greater measure  of 
agreement,  it was  pointed  out  in  discussion  that simple,  classical 
examples  of mesothelioma  were  included  in  the  early series,  but  only  cases 
of great diagnostic  difficulty had  been  circulated  in  the  latter part of 
the  series.  While  the  postal  circulation of cases  was  a  very  valuable 
means  of  sharing  difficult diagnostic  problems,  it was  felt to  be  essential 
for  all  members  of the  Panel  to  meet  at intervals  to  discuss  the  problem 
cases  around  a  table at which  individual  microscopes  were  provided. 
After  such  discussions  it was  possible  to  obtain  a  consensus  agreement  on 
a  diagnosis  in  the  majority  of cases. 
Over  the years  a  great deal  of experience  had  been  gained  in  seeing  the 
wide  ranging  variants  of this  tumour.  The  difficulties  in  differentiating 
between  some  neoplastic  and  reactive  lesions  - especially in  the 
peritoneum  - were  still  recognised,  and  expertise was  still  being  acquired, 
particularly on  the  basis  of follow-up  studies. 
The  challenge  of interpreting small  biopsy  specimens  had  been  taken  up. 
In  general  terms  the  larger the  sample  of tissue submitted,  the  greater 
was  the  possibility of a  definite diagnosis. 
16 CAUSAL  RELATIONSHIPS 
The  quality of  the  occupational  histories  which  have  accompanied  the 
cases  submitted  to  the  Panel,  and  the  limited  number  of  cases  that have 
been  studied,  have  not  made  it possible  to  come  to  a  valid conclusion 
on  the  causal  relationship of  the  mesothelioms.  However  individual 
members  of  the  Panel,  in  collecting cases  within  their own  Countries, 
have  indicated  that approximately  85%  of mesotheliomas  are  asbestos-
related.  While  the  Panel  is  aware  that in  various  parts  of  the  world 
there  are  cases  of  mesothelioma  which  have  been  related to  the  inhalation 
of non-asbestos  fibres,  none  of  these  have  been  submitted  to  the  CEC 
Mesothelioma  Panel. 
17 EDUCATIONAL  ROLE  OF  THE  PANEl 
The  exchange  of  information  on  asbestos-induced  diseases  between  the 
Member  Countries  was  one  of  the  fundamental  concepts  of  the  Panel.  As 
new  Countries  have  joined the  European  Community,  so  it was  deemed  to  be 
important  that they  had  access  to  the  knowledge  and  experience  of those 
already  in  the  Community.  When  Professor  Delides  joined  the  Panel  as  the 
representative of Greece,  he  invited Professor Jones  to  address  the 
Hellenic  Society of Anatomic  Pathology  at a  national  meeting  in  Halkis 
in  1987.  The  problems  of asbestos-induced  diseases  were  broadly  covered, 
together with  an  update  of  diagnostic methods,  epidemiology  and  the 
mineralogical  association with  tumours  of the  mesothelium.  This 
preliminary  presentation  was  followed  in  December  1988  by  a  joint meeting 
in  Athens  between  the  full  CEC  Mesothelioma  Panel  and  the  Hellenic  Society 
of Anatomic  Pathology. 
At  the  Athens  meeting  the  members  of  the  Mesothelioma  Panel  presented  the 
merits  of various  pathological  investigative techniques.  Dr  Lund  and 
Professor Jones  outlined the  gross,  histological  and  cytological  criteria. 
Dr  Planteydt emphasised  the  value  of  the  diastase-PAS  stain  in  distinguishing 
the  epithelial  component  of mesotheliomas  from  secondary  deposits  of 
adenocarcinomas.  Further differentiation  using  immunohistochemical  stains, 
especially CEA,  Keratin  and  Vimentin  were  discussed. 
Dr  Nebut  (France)  cited the  value  of electron microscopy. 
Professor Otto  (Germany)  described  the  techniques  for  identification and 
quantification of asbestos  bodies  and  fibres  by  light microscopy,  using 
the  millipore filtration method. 
Professor  Donna  presented  further  results of  his  mesothelial  cell-specific 
stain and  of  his  morphometric  studies. 
18 An  important  additional  contribution  to  the  joint meeting  in  Athens  was 
made  by  experts  who  presented  some  non-pathological  aspects  of  the  problems 
associated with  asbestos  and  other mineral  fibre-induced  diseases. 
Professor  J  Corbett  Macdonald  (United  Kingdom)  discussed  the  Epidemiology 
of  Diseases  due  to  Asbestos  and  other Mineral  Fibres. 
Professor  F D Pooley  (United  Kingdom)  discussed  the  Mineralogy  of  Fibrous 
Particles which  are  Harmful  to  Man.  He  described  his  techniques  for 
measuring  the  fibre  concentration  and  the  type  of minerals  in  lung  tissue. 
DrS  Raucan  (Turkey)  presented  studies  of Mesothelioma  and  other  Pleural 
Diseases  in  Turkey. 
Dr  Planteydt  described  the  Organisation  and  Working  of  the  Netherlands 
Mesothelioma  Panel. 
Dr  Wagner  presented  an  update  on  the  Biological  Effects  of Mineral  and 
Man-made  Fibres. 
The  meeting  ended  with  a slide seminar  when  discussions  took  place  on  the 
pre-circulated cases  which  had  been  sent to  pathologists  in  Greece  from 
the  Nottingham  centre. 
The  meeting  in  Athens  thus  provided  not  only  a  useful  review  opportunity 
for  the  Members  of  the  Mesothelioma  Panel,  but  also  a comprehensive 
coverage  of  the  subject of  diseases  associated with  mineral  fibre inhalation 
for  the  Hellenic  Society  of Anatomic  Pathology. 
19 ACHIEVBMENTS  AND  THE  FUTURE 
1.  By  exchanging  information  and  diagnostic  problems  over  the  years,  the 
CEC  Mesothelioma  Panel  has  fulfilled one  of  its basic  objectives  -that 
of  standardizing  the  diagnostic  criteria for  this  tumour.  This  information 
has  been  made  available  throughout  the  European  Community  in  the 
publication 
11A Colour  Atlas  of Mesothelioma .. ,  sponsored  by  the  Commission. 
2.  Although  no  direct links  have  been  created  between  Panel  members  and 
their own  National  Mesothelioma  Registers,  the  quality of diagnosis  of 
pathologists  generally  has  improved  so  that the  information  on  Death 
Certificates  is  now  more  reliable.  However  there  is still  room  for 
improvement,  particularly in  recording  the site of  the  primary  mesothelioma  -
an  omission  which  is  unnecessarily often  prevalent.  It is  recommended  that 
the  acceptance  for  registration of a  Death  Certificate should  depend  on 
this  information  being  provided. 
At  the  Panel  Meeting  in  Dublin  in  1991  three  new  members  were  welcomed:-
Dr  F Borderas  (Spain) 
Dr  D Jacobovitz  (Belgium) 
Dr  M Ramalhinho  (Portugal) 
The  Panel  was  also  pleased  to  welcome  Professor J  Sugar  (Hungary)  and 
Dr  M  Brockman  (Germany)  as  observers. 
By  appointing  a  pathologist from  each  Member  Country  to  serve  on  the  Panel, 
it is  hoped  that Registers  of Mesothelioma  cases  in  each  Member  Country 
are  being  established on  a  basis  of  good  diagnostic  information. 
3.  A good  channel  of communication  between  pathologists  from  all  the 
Member  Countries  of  the  European  Community  has  been  established through 
20 the  medium  of  the  Panel  representatives.  It is  hoped  that the  joint 
testing of  new  techniques  of diagnosis  will  continue,  that detailed 
mineralogical  evaluation  can  be  carried out  on  lung  tissue  to  increase 
the  knowledge  of causation  of  mesotheliomas.  To  this  end  it is essential 
that autopsies  are  carried out  on  all  those  who  die  of occupationally-
related diseases.  This  aspect  is worrying,  as  all  the  information  we 
have  concerning  autopsy  rates  in  the  Member  Countries  indicates  that there 
is a  progressive  decline  in  this essential  field of  investigation.  The 
Panel  recommends  that this  trend  be  reversed  in  the  future. 
4.  In  order  to  make  the  best  use  of material  already  available,  a  bank 
of formalin-fixed  pleural  and  peritoneal  tumours  and  lung  tissue  has  been 
established.  This  consists  of over  360  autopsy  samples  which  have  been 
collected  by  Professor Jones  over  a  ten  year  period  (1977  - 1987).  These, 
and  subsequent  specimens  (1987  onwards)  are  being  added  to  the  large 
collection of  mesotheliomas  stored  in  Penarth  by  Dr  Wagner  and  Dr  Gibbs. 
All  this material  is available to  those  working  on  specific research 
projects within  the  European  Community. 
5.  With  regard  to  the  amount  of  biopsy  material  required  to  make  a 
definite diagnosis  of mesothelioma  (or a definite rejection of  the  diagnosis), 
the  Panel  note  that  in  general,  the  more  material  that is available  for 
examination,  the  greater  is  the  chance  of a  diagnosis.  Because  of the 
variability of the  tumour  appearance  in  different parts,  sampling  assumes 
great  importance.  Because  it is desirable  to  make  the  smallest surgical 
incision  to  obtain  biopsy  material,  it is  recommended  that  thoracoscopy  or 
peritoneoscopy  examinations  are  carried out,  with  multiple  small  biopsies 
taken  from  different sites.  While  open  thoracotomy  or  laparotomy  will 
give  a wider  opportunity  of collecting  larger amounts  of  biopsy  material, 
21 there  is  a  tendency  for  tumour  to  spread  through  the  chest or  abdominal 
wall  during  succeeding  months.  While  the  same  complication  may  follow 
at thoracoscopy/peritoneoscopy  or  simple  needle  biopsy  sites,  the  tendency 
for this  procedure  to  lead  to distressing  symptoms  for  the  patient is 
minimised 
6.  Further  work  is  to  be  carried out  on  the  establishment  of  the  dose/ 
response  relationship  between  asbestos  exposure  and  mesothelioma  formation. 
This  work  is  in  progress,  using  those  cases  which  are  available  in 
individual  Member  Countries  in  whom  post  mortem  mineral  analyses  have 
taken  place.  The  degree  of severity of  asbestosis  is also  being  evaluated 
in  these  cases.  The  cases  which  have  been  submitted  for diagnostic 
opinion  to  the  Panel  have  not  been  suitable for this  type  of evaluation. 
7.  The  Panel  has  achieved  considerable  progress  in  defining  the  diagnostic 
criteria for  mesotheliomas,  for devising  a  classification system  and  a 
voting  system  concerning  the  confidence  of diagnosis.  There  remains  much 
to  be  done  in  the  future,  particularly in  developing  a  positive selective 
stain for mesothelial  cells,  in  pursuing  morphometric  studies,  and  in 
evaluating  dose/response  information.  The  establishment of a communications 
system  throughout  the  European  Community  via  the  Members  of the  Mesothelioma 
Panel  has  been  a most  rewarding  experience. 
8.  It is  hoped  that the  information  in  this  publication will  be  of  help 
to all  those  who  have  an  interest in  diseases  associated with 
occupational  or  environmental  factors  (especially asbestos),  and  that it will 
encourage  pathologists  throughout  the  European  Community  to  refer cases 
of diagnostic  difficulty or  interest to  their national  representative for 
consideration  by  the  CEC  Mesothelioma  Panel. 
22 Illustrations for the  article 
on  the 
FORMATION  &  FUNCTION  OF  THE  MESOTHELIOMA  PANEL 
OF  THE 
COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
1.  Cross  section  of  a  lung  and  pleura to  show  the  selective spread 
of  pleural  mesothelioma  along  the  serosal  surfaces. 
2.  Cross  section  of  the  intestines to  show  the  selective  spread  of 
a  peritoneal  mesothelioma  along  the  serosal  surfaces. 
3.  Microsocopic  structure of  a mesothelioma  to  show  the epithelial 
component  of  the  tumour. 
4.  Microscopic  structure of  a mesothelioma  to  show  the  connective 
tissue component  of  the tumour. 
5.  Spectrum  of  histological  variation  of  diffuse malignant  mesothelioma. 
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26 APPENDIX  II 
CASE  FOR  REFER~  'ID THE  C.E.C.  r1ESOYrlELIO-~. PANEL 
Source of material  Ref.  no. 
Narre  ...................................  Sex  ~.ale I  Fanale 
Date of birth .........................  .  Date of death .....•......... 
e>c=~tional history ..•......••.•..•.....•.••....•............  · • · · · · · • 
........................................................................ 
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Asbestos exnosure  Yes I  No I  Unknown 
If yes,  length of exoosure in IOOnths  •••••••••••••• 
Clinical history  (including duration in IrDnths) 
....................................................................... 
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.  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 
Cigarette sooker  Yes I  No  I  1Jnkno..1n 
Pleural plaques  Yes  I  No  I  unknown 
Autopsy  Yes  I  No 
If yes  ,  Au"to'psy'  f indi..rlg's  • • • • • • • • • • • ••••••••••••••••••••••••••••••••••• 
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Mineral Analysis  Yes  I  No 
If yes,  res'Ul  'ts  •••••••••••••••••••  • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • 
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27 APPENDIX  III 
C.E.C.  MESOTHELIOMA  PANEL 
~.E.C.  Code  ~~o: 
DIAG~OSIS 
1.  DIFFUSE  MALIQU\NT  MESOTHELI~  0 
G 
0 
G 
0 
'F  I 
2. lCl' A  DIFFUSE MALIGNANT  MESOTHELI<MIA 
Patholoc;ist: 
Definite  ~esothelioma 
Probable  mesothelioma 
Possible mesothelioma 
Probably  not  mesothelioma 
Definitely not  mesothelioma 
Unsuitable material 
D 
D 
0 
D 
0 
D 
Suggested alternative diagnosis ....................................  . 
3. COMMENTS 
4. Do  you  consider this case  to  be  of  special  interest to  be  discussed 
at a  future  meeting.  YES  I  NO 
DATE .  . ................................  .  SIGNED  .....................  . 
28 APPENDIX  IV 
OPINIONS 
C.E.C.  187  {Ireland  T.ll.A.  58.86) 
A A A A A A A A A  B  c 
Suggested  alternative diagnosis 
COMMENTS 
CEA  negative 
Diffuse  epithelial  well  differentiated mesothelioma 
D-PAS  negative 
Peripheral  lung  adenocarcinoma  cannot  be  100%  excluded. 
JSPJ/VGB 
20.2.87 
29 APPENDIX  V 
SUMMARY  OF  RESULTS  OF  THE  FIRST  200  CASES 
SUBMITTED  TO  THE  CEC  MESOTHELIOMA  PANEl 
Number  of  cases  with  sufficient diagnostic material  194 
Number  of  cases  with  insufficient diagnostic  material  6 
Number  of cases  on  which  an  agreed  diagnosis  was  made  184 
Number  of  cases  on  which  an  agreed  diagnosis  could  not  be  made  10 
Agreed  diagnosis 
Diffuse  Malignant  Mesothelioma  of  pleura  90 
Diffuse  Malignant  Mesothelioma  of  peritoneum  19 
Serosal  tumours  other than  mesothelioma  64 
Reactive  lesions  11 
Serosal  tumours  other than  diffuse malignant  mesothelioma  were  mainly 
metastatic carcinomas,  the majority which  were  derived  from  primary  lung 
tumours. 
Other  primary  tumour  sites were:-
Kidney 
Pancreas 
Testis 
Ovary 
Malignant  melanoma  of skin 
Other  lesions  of  the pleura were:-
Primary  sarcomas 
Anaplastic  tumours  of  unclassifiable type 
Benign  localised mesothelioma  of  pleura 
Adenosquamous  carcinoma  of  pleura 
30 Benign  mesothelioma  of  pleura with  malignant 
transformation  to  adenocarcinoma 
Benign  adenocarcinomatoid  tumour  of  peritoneum 
Benign  papillary mesothelioma  of  peritoneum 
Benign  cystic mesothelioma  of  peritoneum 
Reactive  hyperplasia  of  peritoneum 
Retroperitoneal  cyst 
Thymoma 
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